Cingulate Inc.
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is …
Biotechnology
US, Kansas City [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Cingulate Inc. has no acquisition track records yet.
M&A Deals · History
Cingulate Inc. has no acquisition track records yet.